Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;32(5):884-895.
doi: 10.1038/s41594-024-01467-4. Epub 2025 Jan 23.

Cryo-EM analysis of complement C3 reveals a reversible major opening of the macroglobulin ring

Affiliations

Cryo-EM analysis of complement C3 reveals a reversible major opening of the macroglobulin ring

Trine Amalie Fogh Gadeberg et al. Nat Struct Mol Biol. 2025 May.

Abstract

The C3 protein is the central molecule within the complement system and undergoes proteolytic activation to C3b in the presence of pathogens. Pattern-independent activation of C3 also occurs via hydrolysis, resulting in C3(H2O), but the structural details of C3 hydrolysis remain elusive. Here we show that the conformation of the C3(H2O) analog, C3MA, is indistinguishable from C3b. In contrast, the reaction intermediate C3* adopts a conformation dramatically different from both C3 and C3MA. In C3*, unlocking of the macroglobulin (MG) 3 domain creates a large opening in the MG ring through which the anaphylatoxin (ANA) domain translocates through a transient opening. C3MA formation is inhibited by an MG3-specific nanobody and prevented by linking the ANA domain to the C3 β-chain. Our study reveals an unexpected dynamic behavior of C3 and forms the basis for elucidation of the in vivo contribution of C3 hydrolysis and for controlling complement upon intravascular hemolysis and surface-contact-induced activation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: G.R.A., H.P. and R.K.J. are inventors on patents describing the hC3Nb2 nanobody and the EWEµH fusion protein. H.G.O. is co-founder of Commit Biologics, which has licensed these patents. The remaining authors declare no competing interests.

Similar articles

References

    1. Muller-Eberhard, H. J. & Götze, O. C3 proactivator convertase and its mode of action. J. Exp. Med. 135, 1003–1008 (1972). - PubMed - PMC - DOI
    1. Fearon, D. T., Austen, K. F. & Ruddy, S. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement. J. Exp. Med. 138, 1305–1313 (1973). - PubMed - PMC - DOI
    1. Pangburn, M. K., Schreiber, R. D. & Muller-Eberhard, H. J. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J. Exp. Med. 154, 856–867 (1981). - PubMed - DOI
    1. Pangburn, M. K. Initiation of the alternative pathway of complement and the history of ‘tickover’. Immunol. Rev. 313, 64–70 (2022). - PubMed - DOI
    1. Nilsson, B. & Nilsson Ekdahl, K. The tick-over theory revisited: is C3 a contact-activated protein? Immunobiology 217, 1106–1110 (2012). - PubMed - DOI

LinkOut - more resources